Cargando…
P1693: THROMBOMODULIN RESISTANCE: A NEW PROTHROMBOTIC PATHWAY IN COVID-19
Autores principales: | Montaño, A., Marco, A., López Jaime, F. J., Fernández Bello, I., Márquez Gómez, I., Reguera Iglesias, J. M., Muñoz Pérez, M. I., Marco, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430140/ http://dx.doi.org/10.1097/01.HS9.0000849628.12518.1d |
Ejemplares similares
-
Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19
por: Montaño, Adrián, et al.
Publicado: (2022) -
P1656: PROGRESSIVE WORSENING OF PROTHROMBOTIC PROFILE IN PATIENTS WITH AGGRESSIVE LYMPHOMA ON CHEMOTHERAPY
por: Jaime, Francisco José López, et al.
Publicado: (2023) -
P1693: PATIENT-REPORTED OUTCOMES IN LYMPHOMA TRIALS: A SYSTEMATIC REVIEW
por: Laane, Edward, et al.
Publicado: (2023) -
1693. Risk Factors and Outcomes of Histologic Acute Graft Pyelonephritis following Kidney Transplantation
por: Powers, Harry Ross, et al.
Publicado: (2020) -
P1699: ANTITHROMBIN DEFICIENCY IS ASSOCIATED WITH PROTHROMBOTIC FIBRIN CLOT PHENOTYPE
por: Zabczyk, M., et al.
Publicado: (2022)